Location History:
- Seattle, WA (US) (2002)
- Caulfield Nth, AU (2000 - 2003)
- Victoria, AU (2006)
- Parkville, AU (2014 - 2015)
- Kew, AU (2013 - 2021)
Company Filing History:
7 out of 451 
6 out of 122 
1 out of 1 Years Active: 2000-2021
Title: **Eugene Maraskovsky: Innovator in Blood Coagulation Research**
Introduction
Eugene Maraskovsky is a prominent inventor based in Kew, Australia, recognized for his significant contributions to the field of blood coagulation and immunology. With an impressive portfolio of 15 patents, he stands out as a key figure in medical innovations aimed at improving therapeutic outcomes for patients with coagulation disorders.
Latest Patents
Among Maraskovsky's notable recent inventions is the patented method for the "Modulation of FVIII immunogenicity by truncated VWF." This invention involves a recombinant polypeptide that includes a truncated von Willebrand Factor (VWF) designed to bind to blood coagulation Factor VIII (FVIII). The primary objective is to reduce the immunogenicity of FVIII when administered to patients suffering from various blood coagulation disorders. This approach opens new avenues for treating patients by enhancing the efficacy and safety of FVIII therapies.
Another significant patent is focused on "Compositions and methods for targeting type 1 interferon producing cells." This innovative method offers a treatment strategy for autoimmune conditions such as lupus, Sjögren's syndrome, and scleroderma. It utilizes an immunoglobulin that binds to the interleukin 3 receptor alpha chain, effectively depleting specific immune cells to reduce the disease's impact.
Career Highlights
Throughout his career, Maraskovsky has worked with renowned organizations, including Immunex Corporation and CSL Limited. His efforts in these companies reflect his commitment to advancing medical science through research and development. He has played an integral role in formulating biological solutions that address pressing health issues.
Collaborations
Eugene Maraskovsky has collaborated with distinguished scientists in his field, including Dirk M Anderson and Laurent J Galibert. These partnerships have resulted in groundbreaking research and innovations that contribute significantly to our understanding of blood coagulation and immune responses.
Conclusion
Eugene Maraskovsky's dedication to medical innovation is evident through his numerous patents and collaborative efforts. His work not only highlights the importance of research in developing effective therapies but also serves to inspire future generations of inventors and researchers in the medical field. As he continues to innovate, his contributions will undoubtedly play a crucial role in improving patient care and treatment modalities.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.